CAH Cardinal Health, Inc. Common Stock
Cardinal Health, Inc. Common Stock について Wikipediaからの企業概要
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
続きを読む
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
History
Founded in 1971 as Cardinal Foods by Robert D. Walter, the company was initially a food wholesaler. After acquiring the Bailey Drug Company in 1979, it began whole selling drugs. The company went public on the NASDAQ stock exchange in 1983.
In 1988, Walter sold Cardinal Health's food operations to Roundy's. From 1991 to 1996, the company's sales grew from $1.2 billion to $8.9 billion. The company changed its name to Cardinal Health in 1994, and became the third-largest pharmaceutical wholesaler in the United States.
2000–2019
R. Kerry Clark, a former executive and vice chairman at Procter & Gamble, was appointed president and CEO in April 2006, with Robert D. Walter retaining Chairmanship of the board. In September 2008, the company announced Clark and Walter would retire and George S. Barrett would become the chairman and CEO.
In 2009, Cardinal Health completed the spin-off of its clinical and medical products businesses into an independent medical technology company called CareFusion with David Schlotterbeck as CEO. Cardinal Health is now traded on the NYSE under symbol CAH.
In December 2013, it was announced that Cardinal Health would partner with CVS Caremark to form a generic drug sourcing operation in the United States. The venture was named Red Oak Sourcing and began operations in July 2014.
Between 2014 and 2016, Cardinal, alongside McKesson Corporation, and AmerisourceBergen, spent $13 million lobbying Congress to pass Congressman Tom Marino's "Ensuring Patient Access and Effective Drug Enforcement Act". The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President Barack Obama in April 2016.
In January 2018, Michael Kaufmann assumed the role of CEO after serving as CFO of the company.
Opioid lawsuits
In 2019, Cardinal was one of several drug distributors named in lawsuits related to the opioid crisis in the US. In July 2021, Cardinal Health and other pharmaceutical companies agreed to participate in a $26 billion settlement. Cardinal will pay $6.4 billion over 18 years.
In May 2020, Oklahoma Attorney General Mike Hunter sued Cardinal Health in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against AmerisourceBergen and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets."
2020–present
As of August 2021, it is ranked 14 on the Fortune 500 list with FY2020 annual revenue of $152.9 billion. The firm employs 57,000 people worldwide.
Acquisitions
In 1995, Medicine Shoppe International, the country's largest franchiser of retail pharmacies, was acquired. The merger represented the first non-distribution acquisition by Cardinal Health.
In 1996, Cardinal Health acquired Pyxis Corporation, a company that developed automated pill dispensers for hospitals, for $867 million.
In 1997, Cardinal Health planned to purchase Bergen Brunswig Corp., to which McKesson Corporation responded with a bid to purchase Amerisource. Instead, Amerisource and Bergen merged into AmerisourceBergen. Later that year, Cardinal Health completed the acquisition of Owen Healthcare, the second-largest provider of pharmacy management services in the U.S. at the time.
In 1999, the firm acquired the Chicago-based medical products manufacturer and distributor, Allegiance Healthcare (formerly a division of Baxter Healthcare). In 2001, the company acquired Bindley Western Industries, a wholesale distributor of pharmaceuticals based in Indianapolis.
In April 2006, Cardinal Health purchased Niagara Falls-based ParMed Pharmaceuticals for $40.1 million. In June 2007, the firm announced the completion of a tender offer for VIASYS Healthcare.
In June 2010, Cardinal Health announced plans to purchase Healthcare Solutions Holding, a specialty pharmaceutical services company, for $517 million. In December 2010, the company acquired Kinray, an independent pharmaceutical wholesaler, increasing Cardinal Health's presence in the independent pharmacy market by 40 percent. From 2010 to 2014, Cardinal Health acquired 18 companies including Yong Yu, a Chinese drug distributor. Cardinal sold Yong Yu in 2017 to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion.
On March 18, 2013, Cardinal Health acquired the Twinsburg, Ohio-based privately held medical supply distributor AssuraMed, and with it its subsidiaries including Edgepark Medical Supplies, for $2.7 billion. AssuraMed was backed by private equity firms Clayton, Dubilier & Rice and Goldman Sachs Alternatives.
In July 2014, Cardinal Health and CVS formed Red Oak Sourcing, the largest generic drug sourcing operation in the United States. The companies started buying generic drugs around the world to sell in U.S. markets.
In March 2015, Cardinal Health signed an agreement to acquire Johnson & Johnson's Cordis (medical) division, a cardiology and endovascular device manufacturer, for $1.94 billion. The acquisition was completed on October 4, 2015. Cardinal sold the division in August 2021 to Hellman & Friedman, a private equity firm, for $1 billion.
In April 2017, Cardinal Health announced the plan to acquire the patient product portfolio from Medtronic for $6.1 billion. The acquisition was completed on July 30, 2017.
In November 2024, Cardinal Health announced the plan to acquire Advanced Diabetes Supply Group (ADSG), a leading national direct-to-patient provider of diabetes medical supplies, for about $1.1 billion with plans to merge the company into its at-Home Solutions business. The at-Home Solutions business includes Edgepark Medical Supplies of Twinsburg, Ohio and United States Medical Supply (US MED) of Doral, Florida. The acquisition was complete by April 2024.
In August 2025, Cardinal Health announced that it would acquire a 75% stake in Solaris Health, the largest urology management services organization (MSO) in the United States, for $1.9 billion in cash.
In July 2026, Cardinal Health agreed to acquire AdaptHealth's diabetes health business and medical-supply provider Strive Medical in separate transactions worth approximately US$360 million in total. The acquisitions were intended to expand its at-Home Solutions business in diabetes and urological care.
Controversy
Role in the Opioid epidemic
Multiple legal settlements have demonstrated Cardinal Health's role in the US Opioid epidemic, though the company never admitted wrongdoing:
December 2016: Cardinal Health settled for $44 million for violations of the Controlled Substances Act brought in allegations from United States Attorneys in districts from Maryland, New York, Florida and Washington.
July 2021: Cardinal Health agreed to pay $6.4 billion to settle thousands of US lawsuits. They were one of four companies to pay $26 billion, including Johnson & Johnson, AmerisourceBergen and McKesson.
May 2022: Settled a derivative suit on behalf of shareholders for $124 million.
August 2024: Settlement with various health plans including insurers and third-party payers for $92.7 million.
August 2024: Settlement with the City of Baltimore for $152.5 million.
Restatements
In September 2004, Cardinal Health announced plans to restate past results for fiscal 2001, 2002, 2003, and the first three quarters of 2004 downward, after an accounting review and an ongoing federal investigation. In 2005, in connection with the Audit Committee's conclusions reached in September and October 2004, the company made certain reclassification and restatement adjustments to its fiscal 2004 and prior historical consolidated financial statements. According to The Wall Street Journal, "Analysts called the restatement decision troubling, yet limited in scope."
FDA action
In August 2006, Cardinal Health ceased production of its Alaris SE infusion pump after approximately 1300 units were seized by the United States Food and Drug Administration (FDA). In February 2007, Cardinal Health signed a consent decree with the FDA which promised procedures to guarantee the safety of the Alaris SE. After FDA inspections, Cardinal Health entered into a further consent agreement with the FDA in 2009.
DEA investigation into Oxycodone diversion
In 2008, Cardinal Health agreed to pay $34 million in civil penalties to settle DEA allegations that it failed to report suspicious orders of hydrocodone. The fine followed a 10-month DEA suspension of a Lakeland, Florida distribution facility and two others in New Jersey and Washington. On February 2, 2012, the Drug Enforcement Administration again suspended the license of the firm's Lakeland distribution center to distribute controlled substances on charges that it had allowed four Florida pharmacies to purchase excessive amounts of controlled substances, in particular oxycodone.
Cardinal Health obtained a restraining order against the suspension, but the suspension was upheld on February 29 by a Federal district court because the court agreed with the DEA that Cardinal Health's activities represented an "imminent danger to the public." The company stated that it blocked two of the pharmacies, (Brooks Pharmacy in Bonita Springs, Florida, and Gulf Coast Medical in Panama City, Florida), and notified the corporate owners of the two pharmacies that were part of national chains, two CVS stores in Sanford, Florida.
In February 2012, Joseph Rannazzisi, chief of the Drug Enforcement Administration’s Office of Diversion Control, issued immediate suspension orders against Cardinal's supply of oxycodone to suspected pill mills. These orders were filed after Deputy Attorney General James M. Cole met with Rannazzisi to ask if he had met with Cardinal about the investigation. Cole stated that he believed “it made good sense to listen to what Cardinal had to say” regarding the investigation. That year, Cardinal and the DEA reached a settlement that suspended Cardinal's facility in Lakeland, Florida from selling pain killers or other drugs for two years. In 2016, Cardinal was fined $44 million for after the investigation concluded.
In January 2022, Cardinal Health, Johnson & Johnson, McKesson, and AmerisourceBergen agreed to pay $26 billion to settle with all but five of the states suing them. Had the states gone to court, the companies could have faced up to $95 billion in penalties.
Finances
Annual financial statistics are displayed below:
Cardinal Health Foundation
The Cardinal Health Foundation is the charitable arm of Cardinal Health. The company makes annual product donations of over $9 million through international relief organizations and provides up to $1,000 in matching funds for every Cardinal Health employee that makes a charitable donation. In 2008, the foundation established its E3 Grant Program. Over the past seven years, the Foundation has invested more than $7.15 million in funding to 241 hospitals, health systems or other health-related organizations.
Cardinal Health also supports organizations such as Ronald McDonald House Charities, and was named Benefactor of the Year at the 2011 Corporate Caring Awards. In 2015, the foundation contributed $3 million to the Solutions for Patient Safety project, which has raised over $11 million nationally for efforts to improve safety initiatives in children's hospitals.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
CAH 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
CAH 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
配当金 利回り、配当性向、配当履歴、5年CAGR
| 権利落ち日 | 金額 |
|---|---|
| 2026年7月1日 | $0.5160 |
| 2026年4月1日 | $0.5110 |
| 2026年1月2日 | $0.5110 |
| 2025年10月1日 | $0.5110 |
| 2025年7月1日 | $0.5110 |
| 2025年4月1日 | $0.5060 |
| 2025年1月2日 | $0.5060 |
| 2024年10月1日 | $0.5060 |
| 2024年7月1日 | $0.5060 |
| 2024年3月28日 | $0.5010 |
| 2023年12月29日 | $0.5010 |
| 2023年10月2日 | $0.5010 |
| 2023年6月30日 | $0.5010 |
| 2023年3月31日 | $0.4960 |
| 2022年12月30日 | $0.4960 |
| 2022年9月30日 | $0.4960 |
| 2022年6月30日 | $0.4960 |
| 2022年3月31日 | $0.4910 |
| 2021年12月31日 | $0.4910 |
| 2021年9月30日 | $0.4910 |
CAH アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
- 強い買い 8 34.8%
- 買い 12 52.2%
- 保有 3 13.0%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
16 アナリスト · 2026-08-21決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年12月31日 | $2.91 | $2.44 | 0.47% |
| 2026年6月30日 | $2.91 | $2.44 | 0.47% |
| 2026年3月31日 | $3.17 | $2.82 | 0.35% |
| 2025年12月31日 | $2.63 | $2.40 | 0.23% |
| 2025年9月30日 | $2.55 | $2.20 | 0.35% |
| 2025年6月30日 | $2.08 | $2.06 | 0.02% |
| 2025年3月31日 | $2.35 | $2.19 | 0.16% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 15
| 指標 | トレンド | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Cost of Revenue | $244.47B | $214.41B | $219.41B | $198.10B | $174.84B | $155.69B | $146.05B | $138.70B | $129.63B | $123.43B | $115.00B | $96.82B | |
| Gross Profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B | $7.18B | $6.54B | $6.54B | $5.71B | |
| SG&A Expense | $6.13B | $5.38B | $5.00B | $4.80B | $4.51B | $4.53B | $4.57B | $4.48B | $4.60B | $3.77B | $3.65B | $3.24B | |
| Operating Income | $2.61B | $2.27B | $1.24B | $752M | $-607M | $472M | $-4.10B | $2.06B | $126M | $2.12B | $2.46B | $2.16B | |
| Interest Expense | $348M | $215M | $51M | $84M | $147M | $180M | $238M | $294M | $329M | $201M | $178M | $141M | |
| Other Non-op | $31M | $41M | $9M | $-5M | $-22M | $47M | $1M | $-15M | $-23M | $5M | $-5M | $7M | |
| Pretax Income | $2.17B | $2.10B | $1.20B | $663M | $-784M | $323M | $-3.77B | $1.75B | $-228M | $1.92B | $2.28B | $1.97B | |
| Income Tax | $469M | $532M | $348M | $332M | $153M | $-289M | $-79M | $386M | $-487M | $630M | $845M | $755M | |
| Net Income | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| EPS (Basic) | $7.27 | $6.48 | $3.48 | $1.27 | $-3.37 | $2.09 | $-12.61 | $4.55 | $0.82 | $4.06 | $4.36 | $3.66 | |
| EPS (Diluted) | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 | $2.08 | $-12.61 | $4.53 | $0.81 | $4.03 | $4.32 | $3.62 | |
| Shares (Basic) | 236,000,000 | 241,000,000 | 245,000,000 | 261,000,000 | 279,000,000 | 292,000,000 | 293,000,000 | 300,000,000 | 313,000,000 | 317,000,000 | 327,000,000 | 332,000,000 | |
| Shares (Diluted) | 237,000,000 | 242,000,000 | 247,000,000 | 262,000,000 | 279,000,000 | 294,000,000 | 293,000,000 | 301,000,000 | 315,000,000 | 320,000,000 | 330,000,000 | 335,000,000 | |
| EBITDA | $3.57B | $3.06B | $1.95B | $1.42B | $96M | $1.25B | $-3.19B | $3.06B | $1.16B | $2.84B | $3.10B | $2.61B |
貸借対照表 25
| 指標 | トレンド | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.72B | $3.41B | $2.77B | $2.53B | $1.76B | $6.88B | $2.36B | $4.62B | |
| Short-term Investments | · | · | $200M | · | · | · | · | · | · | $65M | $113M | $91M | |
| Receivables | $13.81B | $13.24B | $12.08B | $11.11B | $10.56B | $9.10B | $8.26B | $8.45B | $7.80B | $8.05B | $7.41B | $6.52B | |
| Inventory | $17.30B | $16.83B | $14.96B | $16.12B | $15.64B | $14.59B | $13.20B | $12.82B | $12.31B | $11.30B | $10.62B | $9.21B | |
| Other Current Assets | $2.76B | $2.41B | $2.66B | $2.29B | $2.02B | $2.84B | $1.71B | $1.95B | $1.93B | $2.12B | $1.58B | $1.40B | |
| Current Assets | $38.75B | $36.37B | $34.88B | $33.74B | $32.94B | $31.05B | $25.94B | $25.75B | $24.55B | $28.34B | $21.96B | $21.75B | |
| PP&E (Net) | $3.03B | $2.86B | $2.53B | $2.46B | $2.36B | $2.36B | $2.37B | $2.36B | $2.49B | $1.88B | $1.80B | $1.51B | |
| PP&E (Gross) | $7.97B | $7.52B | $6.70B | $6.31B | $5.88B | $5.59B | $5.33B | $5.17B | $5.26B | $4.63B | $4.48B | $4.03B | |
| Accum. Depreciation | $4.93B | $4.66B | $4.17B | $3.85B | $3.52B | $3.23B | $2.96B | $2.81B | $2.77B | $2.75B | $2.68B | $2.53B | |
| Goodwill | $11.44B | $9.69B | $4.72B | $4.61B | $5.86B | $7.99B | $8.36B | $8.38B | $8.32B | $7.22B | $7.17B | $5.07B | |
| Intangibles | $2.19B | $2.49B | $1.73B | $1.47B | $1.77B | $2.10B | $2.92B | $3.43B | $3.91B | $1.99B | $1.99B | $948M | |
| Other Non-current Assets | $1.88B | $1.71B | $1.26B | $1.07B | $953M | $951M | $1.19B | $1.05B | $682M | $681M | $944M | $866M | |
| Total Assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B | |
| Accounts Payable | $38.28B | $34.71B | $31.76B | $29.93B | $27.13B | $23.70B | $21.37B | $21.54B | $19.68B | $17.91B | $17.31B | $14.37B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | $0 | |
| Current Liabilities | $43.90B | $38.90B | $35.64B | $33.74B | $30.55B | $27.62B | $23.61B | $24.11B | $22.89B | $21.22B | $19.70B | $17.24B | |
| Capital Leases | $861M | $654M | $400M | $375M | $388M | $374M | $341M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $1.75B | $1.81B | $1.95B | $1.70B | $328M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | · | |
| Common Stock | $2.89B | $2.96B | $2.92B | $2.75B | $2.81B | $2.81B | $2.79B | $2.76B | $2.73B | $2.70B | $3.01B | $3.00B | |
| Retained Earnings | $2.01B | $783M | $-286M | $-642M | $-280M | $1.21B | $1.17B | $5.43B | $4.64B | $4.97B | $6.42B | $5.52B | |
| Treasury Stock | $7.61B | $6.37B | $5.68B | $4.91B | $3.13B | $2.19B | $2.07B | $1.79B | $1.22B | $731M | $2.76B | $2.25B | |
| AOCI | $-165M | $-155M | $-167M | $-151M | $-114M | $-34M | $-104M | $-79M | $-92M | $-125M | $-116M | $-23M | |
| Stockholders' Equity | $-2.88B | $-2.78B | $-3.21B | $-2.96B | $-709M | $1.79B | $1.79B | $6.33B | $6.06B | $6.81B | $6.55B | $6.26B | |
| Liabilities + Equity | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B |
キャッシュフロー 19
| 指標 | トレンド | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $956M | $790M | $710M | $692M | $692M | $783M | $913M | $1.00B | $1.03B | $717M | $641M | $451M | |
| Stock-based Comp | $367M | $244M | $121M | $96M | $81M | $89M | $90M | $82M | $85M | $96M | $111M | $110M | |
| Deferred Tax | $91M | $243M | $-104M | $-40M | $14M | $496M | $-961M | $-83M | $-1.01B | $291M | $87M | $219M | |
| Amort. of Intangibles | $361M | $303M | $264M | $281M | $311M | $428M | $512M | $531M | $574M | $395M | $355M | $191M | |
| Restructuring | $106M | $88M | $175M | $95M | $101M | $114M | $122M | $125M | $176M | $56M | $25M | $44M | |
| Other Non-cash | $2.05B | $-441M | $2.18B | $1.82B | $3.27B | $450M | $5.61B | $360M | $2.41B | · | $705M | $545M | |
| Operating Cash Flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.17B | $2.43B | $1.96B | $2.72B | $2.77B | $1.18B | $2.97B | $2.54B | |
| CapEx | $649M | $547M | $511M | $481M | $387M | $400M | $375M | $328M | $384M | $387M | $465M | $300M | |
| Investing Cash Flow | $-2.58B | $-5.59B | $-1.85B | $-454M | $567M | $-378M | $493M | $338M | $-5.61B | $-405M | $-4.08B | $-849M | |
| Debt Issued | $1.00B | $2.90B | $1.14B | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $347M | $2.46B | $357M | $-579M | $-885M | $-570M | $-1.40B | $-1.10B | $-954M | $-310M | $-6M | $-1.22B | |
| Stock Repurchased | $1.36B | $765M | $750M | $2.00B | $1.00B | $200M | $350M | $600M | $550M | $600M | $651M | $1.04B | |
| Net Stock Activity | $-1.36B | $-765M | $-750M | $-2.00B | $-1.00B | $-200M | $-350M | $-600M | $-550M | $-600M | $-651M | $-1.04B | |
| Dividends Paid | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M | |
| Financing Cash Flow | $-1.60B | $1.94B | $-847M | $-3.05B | $-2.46B | $-1.32B | $-2.20B | $-2.29B | $-2.28B | $3.75B | $-1.14B | $60M | |
| Net Change in Cash | $982M | $-1.26B | $1.06B | $-669M | $1.36B | $636M | $240M | $768M | $-5.12B | $4.52B | $-2.26B | $1.75B | |
| Taxes Paid | $338M | $444M | $191M | $156M | $-766M | $273M | $368M | $311M | $425M | $686M | $635M | $529M | |
| Free Cash Flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B | $2.03B | $1.58B | $2.39B | $2.38B | $797M | $2.51B | $2.24B | |
| Levered FCF | $4.25B | $1.69B | $3.21B | $2.32B | $2.55B | $1.69B | $1.35B | $2.16B | $2.76B | $662M | $2.39B | $2.15B |
収益性 8
| 指標 | トレンド | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% | 5.4% | 5.6% | |
| Operating Margin | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% | 0.29% | -2.7% | 1.4% | 0.09% | 1.6% | 2.0% | 2.1% | |
| Net Margin | 0.67% | 0.70% | 0.38% | 0.13% | -0.51% | 0.38% | -2.4% | 0.94% | 0.19% | · | 1.2% | 1.2% | |
| Pretax Margin | 0.86% | 0.94% | 0.53% | 0.31% | -0.42% | 0.20% | -2.5% | 1.2% | -0.17% | 1.5% | 1.9% | 1.9% | |
| EBITDA Margin | 1.4% | 1.4% | 0.86% | 0.69% | 0.05% | 0.77% | -2.1% | 2.1% | 0.85% | 2.2% | 2.5% | 2.5% | |
| ROA | 3.1% | 3.2% | 1.9% | 0.60% | -2.1% | 1.4% | -9.0% | 3.4% | 0.64% | · | 4.4% | 4.3% | |
| ROE | -60.5% | -52.1% | -27.6% | -14.7% | -172.5% | 34.1% | -91.1% | 22.0% | 4.0% | · | 22.3% | 19.2% | |
| ROIC | -71.1% | -61.1% | -27.5% | -10.5% | 101.9% | 49.9% | -224.3% | 25.4% | -2.4% | 18.6% | 23.6% | 21.3% |
流動性と支払能力 4
| 指標 | トレンド | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.3 | |
| Quick Ratio | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.1 | 0.0 | · | |
| Interest Coverage | 7.5 | 10.6 | 24.4 | 7.8 | -4.0 | 2.6 | -17.2 | 7.0 | 0.4 | 10.5 | 13.8 | 15.3 |
効率性 3
| 指標 | トレンド | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.6 | 4.5 | 5.1 | 4.7 | 4.1 | 3.8 | 3.7 | 3.6 | 3.4 | 3.5 | 3.8 | 3.7 | |
| Inventory Turnover | 14.3 | 13.5 | 14.1 | 12.5 | 11.6 | 11.2 | 11.2 | 11.0 | 11.0 | 11.3 | 11.6 | 11.1 | |
| Receivables Turnover | 18.8 | 17.6 | 19.6 | 18.7 | 18.4 | 18.7 | 18.3 | 17.9 | 17.3 | 16.8 | 17.5 | 17.2 |
成長率 10
| 指標 | トレンド | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 14.2% | -1.9% | 10.7% | 13.0% | 11.6% | 6.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.4% | 7.1% | 11.8% | 10.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.4% | 7.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 12.1% | 87.0% | 173.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 79.0% | · | 18.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 28.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 9.8% | 83.2% | 158.2% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 73.2% | · | 11.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 22.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | -3.0% | -2.8% | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 6
| 指標 | トレンド | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Net Income TTM | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| P/E | 32.9 | 26.0 | 28.5 | 75.1 | -15.5 | 27.4 | -4.1 | 10.4 | 60.3 | 19.3 | 18.1 | 23.1 | |
| Earnings Yield | 3.0% | 3.8% | 3.5% | 1.3% | -6.5% | 3.6% | -24.2% | 9.6% | 1.7% | 5.2% | 5.5% | 4.3% | |
| Payout Ratio | 28.6% | 31.6% | 58.6% | 201.1% | -59.9% | 93.8% | -15.4% | 42.3% | 226.9% | · | 35.9% | 37.9% | |
| Annual Payout | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M |
損益計算書 15
| 指標 | トレンド | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | $54.88B | $55.26B | $52.28B | $59.87B | $54.87B | $57.44B | $54.65B | $53.42B | $50.50B | $51.47B | $49.59B | |
| Cost of Revenue | $61.11B | $58.44B | $63.23B | $61.69B | $57.96B | $52.76B | $53.32B | $50.38B | $57.98B | $52.93B | $55.59B | $52.91B | $51.61B | $48.69B | $49.78B | $48.00B | |
| Gross Profit | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B | $2.12B | $1.94B | $1.90B | $1.88B | $1.94B | $1.85B | $1.74B | $1.81B | $1.81B | $1.68B | $1.60B | |
| SG&A Expense | $1.62B | $1.54B | $1.50B | $1.46B | $1.48B | $1.31B | $1.31B | $1.28B | $1.28B | $1.27B | $1.27B | $1.19B | $1.23B | $1.17B | $1.18B | $1.20B | |
| Operating Income | $729M | $509M | $707M | $668M | $428M | $730M | $549M | $568M | $401M | $369M | $505M | $-32M | $162M | $604M | $-86M | $123M | |
| Interest Expense | · | · | $88M | $80M | $74M | $74M | $35M | $32M | $9M | $28M | $3M | $11M | $6M | $26M | $24M | $24M | |
| Other Non-op | $26M | $-16M | $11M | $10M | $30M | $9M | $-3M | $5M | $-1M | $1M | $10M | $-1M | $-10M | $-2M | $6M | $-3M | |
| Pretax Income | $554M | $392M | $630M | $598M | $384M | $665M | $511M | $541M | $391M | $342M | $512M | $-44M | $146M | $576M | $-104M | $96M | |
| Income Tax | $154M | $12M | $159M | $144M | $141M | $157M | $110M | $124M | $158M | $80M | $143M | $-33M | $143M | $209M | $-27M | $-3M | |
| Net Income | $398M | $399M | $467M | $450M | $239M | $506M | $400M | $416M | $235M | $261M | $368M | $-12M | $5M | $365M | $-77M | $98M | |
| EPS (Basic) | · | · | · | $1.89 | · | · | · | $1.71 | · | $1.07 | $1.50 | $-0.05 | · | $1.43 | $-0.30 | $0.36 | |
| EPS (Diluted) | · | · | · | $1.88 | · | · | · | $1.70 | · | $1.07 | $1.50 | $-0.05 | · | $1.41 | $-0.30 | $0.36 | |
| Shares (Basic) | -473,000,000 | 235,000,000 | 236,000,000 | 238,000,000 | -484,000,000 | 240,000,000 | 242,000,000 | 243,000,000 | -492,000,000 | 243,000,000 | 245,000,000 | 249,000,000 | -527,000,000 | 256,000,000 | 261,000,000 | 271,000,000 | |
| Shares (Diluted) | -475,000,000 | 236,000,000 | 237,000,000 | 239,000,000 | -487,000,000 | 241,000,000 | 243,000,000 | 245,000,000 | -493,000,000 | 245,000,000 | 246,000,000 | 249,000,000 | -530,000,000 | 258,000,000 | 261,000,000 | 273,000,000 | |
| EBITDA | · | $757M | $941M | $901M | · | $730M | $549M | $750M | · | $367M | $482M | $158M | · | $572M | $-119M | $308M |
貸借対照表 21
| 指標 | トレンド | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | $3.33B | $3.81B | $2.87B | $5.13B | $3.72B | $4.59B | $3.85B | · | $3.99B | $3.65B | $3.49B | |
| Receivables | $13.81B | $13.65B | $13.66B | $13.77B | $13.24B | $12.67B | $12.37B | $11.78B | $12.08B | $11.57B | $11.79B | $11.27B | · | $10.99B | $11.42B | $11.04B | |
| Inventory | $17.30B | $18.01B | $20.12B | $17.56B | $16.83B | $16.16B | $16.90B | $15.62B | $14.96B | $17.28B | $18.45B | $16.99B | · | $16.62B | $17.26B | $15.89B | |
| Other Current Assets | $2.76B | $2.47B | $2.67B | $2.60B | $2.41B | $2.40B | $2.62B | $2.59B | $2.66B | $3.16B | $2.82B | $2.58B | · | $1.90B | $2.26B | $2.27B | |
| Current Assets | $38.75B | $38.06B | $39.23B | $38.54B | $36.37B | $34.59B | $35.76B | $32.91B | $34.88B | $35.73B | $37.66B | $34.69B | · | $33.50B | $34.60B | $32.70B | |
| PP&E (Net) | $3.03B | $2.93B | $2.88B | $2.83B | $2.86B | $2.66B | $2.56B | $2.54B | $2.53B | $2.47B | $2.45B | $2.44B | · | $2.36B | $2.34B | $2.34B | |
| PP&E (Gross) | $7.97B | · | · | · | $7.52B | · | · | · | $6.70B | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.93B | · | · | · | $4.66B | · | · | · | $4.17B | · | · | · | · | · | · | · | |
| Goodwill | $11.44B | $11.41B | $11.61B | $9.71B | $9.69B | $8.91B | $5.49B | $4.72B | $4.72B | $4.79B | $4.02B | $4.03B | $4.61B | $5.00B | $4.99B | $5.67B | |
| Intangibles | $2.19B | $2.28B | $2.37B | $2.40B | $2.49B | $2.11B | $1.95B | $1.66B | $1.73B | $1.72B | $1.35B | $1.41B | · | $1.57B | $1.63B | $1.69B | |
| Other Non-current Assets | $1.88B | $2.00B | $2.00B | $1.75B | $1.71B | $1.60B | $1.25B | $1.23B | $1.26B | $1.17B | $1.10B | $1.15B | · | $951M | $927M | $985M | |
| Total Assets | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B | |
| Accounts Payable | $38.28B | $37.83B | $39.00B | $36.86B | $34.71B | $32.81B | $31.30B | $30.36B | $31.76B | $32.09B | $34.26B | $31.54B | · | $29.60B | $30.08B | $28.36B | |
| Current Liabilities | $43.90B | $41.99B | $43.31B | $40.27B | $38.90B | $36.66B | $35.22B | $34.68B | $35.64B | $36.31B | $38.29B | $35.06B | · | $32.50B | $33.21B | $31.56B | |
| Capital Leases | $861M | · | · | · | $654M | · | · | · | $400M | · | · | · | · | · | · | · | |
| Common Stock | $2.89B | $2.81B | $2.85B | $2.75B | $2.96B | $2.95B | $2.93B | $2.83B | $2.92B | $2.89B | $2.85B | $2.73B | · | $2.82B | $2.75B | $2.58B | |
| Retained Earnings | $2.01B | $1.73B | $1.46B | $1.12B | $783M | $664M | $283M | $14M | $-286M | $-289M | $-425M | $-654M | · | $-342M | $-560M | $-301M | |
| Treasury Stock | $7.61B | $7.22B | $7.03B | $6.58B | $6.37B | $6.38B | $6.03B | $5.96B | $5.68B | $5.70B | $5.72B | $5.40B | $4.91B | $4.55B | $4.25B | $3.88B | |
| AOCI | $-165M | $-161M | $-153M | $-159M | $-155M | $-176M | $-180M | $-155M | $-167M | $-160M | $-155M | $-165M | · | $-142M | $-146M | $-176M | |
| Stockholders' Equity | $-2.88B | $-2.83B | $-2.88B | $-2.88B | $-2.78B | $-2.95B | $-2.99B | $-3.28B | $-3.21B | $-3.27B | $-3.45B | $-3.49B | · | $-2.22B | $-2.21B | $-1.78B | |
| Liabilities + Equity | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B |
キャッシュフロー 17
| 指標 | トレンド | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $241M | $248M | $234M | $233M | $209M | $207M | $192M | $182M | $186M | $177M | $175M | $172M | $176M | $175M | $170M | $171M | |
| Stock-based Comp | $58M | $129M | $87M | $93M | $153M | $31M | $30M | $30M | $33M | $31M | $28M | $29M | $27M | $21M | $25M | $23M | |
| Amort. of Intangibles | $95M | $95M | $84M | $87M | $89M | $77M | $69M | $68M | $73M | $64M | $63M | $64M | $70M | $69M | $71M | $71M | |
| Restructuring | $40M | $25M | $21M | $20M | $27M | $28M | $9M | $24M | $69M | $53M | $28M | $25M | $33M | $16M | $17M | $29M | |
| Other Non-cash | · | · | · | $197M | · | · | · | $-2.27B | · | · | · | $339M | · | · | · | $-281M | |
| Operating Cash Flow | $1.69B | $1.82B | $686M | $973M | $1.52B | $2.92B | $-396M | $-1.65B | $2.08B | $-54M | $1.16B | $528M | $863M | $1.36B | $597M | $23M | |
| CapEx | $264M | $146M | $131M | $108M | $232M | $126M | $99M | $90M | $193M | $112M | $114M | $92M | $217M | $109M | $85M | $70M | |
| Investing Cash Flow | $-281M | $-181M | $-1.98B | $-142M | $-1.63B | $-2.90B | $-976M | $-88M | $166M | $-1.85B | $-105M | $-63M | $-206M | $-91M | $-87M | $-70M | |
| Debt Issued | $0 | $0 | $0 | $1.00B | $0 | $0 | · | · | $0 | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | $488M | · | · | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | |
| Stock Repurchased | $350M | $250M | $383M | $375M | $0 | $375M | $15M | $375M | $0 | $0 | $250M | $500M | $500M | $250M | $250M | $1.00B | |
| Net Stock Activity | · | · | · | $-375M | · | · | · | $-375M | · | · | · | $-500M | · | · | · | $-1.00B | |
| Dividends Paid | $120M | $120M | $122M | $129M | $120M | $124M | $122M | $128M | $122M | $122M | $124M | $131M | $126M | $128M | $129M | $142M | |
| Financing Cash Flow | $-490M | $-483M | $-519M | $-110M | $663M | $-507M | $2.33B | $-540M | $-859M | $1.03B | $-353M | $-666M | $-592M | $-934M | $-362M | $-1.16B | |
| Net Change in Cash | $919M | $1.16B | $-1.82B | $719M | $548M | $-484M | $943M | $-2.27B | $1.39B | $-878M | $710M | $-206M | $58M | $336M | $162M | $-1.23B | |
| Free Cash Flow | · | · | · | $865M | · | · | · | $-1.74B | · | · | · | $453M | · | · | · | $-47M | |
| Levered FCF | · | · | · | $804M | · | · | · | $-1.76B | · | · | · | $456M | · | · | · | $-72M |
収益性 8
| 指標 | トレンド | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 4.1% | 3.6% | 3.6% | · | 3.9% | 3.5% | 3.6% | · | 3.5% | 3.2% | 3.2% | · | 3.5% | 3.2% | 3.2% | |
| Operating Margin | · | 0.84% | 1.1% | 1.0% | · | 1.3% | 0.99% | 1.1% | · | 0.67% | 0.84% | -0.03% | · | 1.1% | -0.23% | 0.28% | |
| Net Margin | · | 0.65% | 0.71% | 0.70% | · | 0.92% | 0.72% | 0.80% | · | 0.47% | 0.61% | 0.01% | · | 0.68% | -0.25% | 0.22% | |
| Pretax Margin | · | 0.64% | 0.96% | 0.93% | · | 1.2% | 0.92% | 1.0% | · | 0.62% | 0.85% | -0.05% | · | 1.1% | -0.27% | 0.22% | |
| EBITDA Margin | · | 1.2% | 1.4% | 1.4% | · | 1.3% | 0.99% | 1.4% | · | 0.67% | 0.84% | 0.29% | · | 1.1% | -0.23% | 0.62% | |
| ROA | · | 0.75% | 0.89% | 0.92% | · | 1.1% | 0.85% | 0.96% | · | 0.58% | 0.78% | 0.01% | · | 0.81% | -0.29% | 0.25% | |
| ROE | · | -13.8% | -15.9% | -14.6% | · | -16.3% | -12.4% | -12.3% | · | -9.4% | -12.5% | -0.19% | · | -23.6% | 21.4% | -56.7% | |
| ROIC | · | -17.4% | -18.3% | -17.6% | · | -18.9% | -14.4% | -13.4% | · | -8.5% | -10.1% | -0.09% | · | -16.4% | 5.1% | -7.8% |
流動性と支払能力 3
| 指標 | トレンド | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.9 | 0.9 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | · | 0.4 | 0.4 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | · | 8.0 | 8.3 | · | 9.9 | 15.7 | 17.8 | · | 11.1 | 60.2 | -1.0 | · | 20.4 | -4.8 | 5.5 |
効率性 3
| 指標 | トレンド | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.3 | · | 1.1 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.1 | |
| Inventory Turnover | · | 3.4 | 3.4 | 3.7 | · | 3.2 | 3.0 | 3.1 | · | 3.1 | 3.1 | 3.2 | · | 3.0 | 3.1 | 3.1 | |
| Receivables Turnover | · | 4.6 | 5.0 | 5.0 | · | 4.5 | 4.6 | 4.5 | · | 4.9 | 5.0 | 4.9 | · | 4.8 | 4.9 | 4.9 |
バリュエーション（TTM） 5
| 指標 | トレンド | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $245.45B | $239.78B | $226.43B | · | $217.29B | $219.85B | $219.24B | · | $217.46B | $214.06B | $206.21B | · | $196.39B | $191.35B | $183.85B | |
| Net Income TTM | · | $1.82B | $1.82B | $1.77B | · | $1.58B | $1.45B | $1.03B | · | $982M | $644M | $374M | · | $-1.00B | $-1.32B | $-973M | |
| P/E | · | · | · | · | · | 32.6 | 28.0 | 26.2 | · | 28.5 | 39.4 | 61.1 | · | · | · | · | |
| Earnings Yield | · | · | · | · | · | 3.1% | 3.6% | 3.8% | · | 3.5% | 2.5% | 1.6% | · | · | · | · | |
| Payout Ratio | · | · | · | 28.7% | · | · | · | 30.8% | · | · | · | 2620.0% | · | · | · | 129.1% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| 収益 | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B |
| 粗利益率 % | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% |
| 営業利益率 % | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% |
| 純利益 | $1.71B | $1.56B | $852M | $330M | $-938M |
| 希薄化後EPS | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 |
貸借対照表
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| 流動比率 | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 |
| クイックレシオ | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 |
キャッシュフロー
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B |
最新ニュース この会社に言及した最近の見出し
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 1,621 提出者 · $31.0B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 156 (-22 前期比) | 80 (-18 前期比) | 524 (-25 前期比) | 552 (+43 前期比) | +3.8M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3,632,811,706 | 15,292,186 | 11.72% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3,258,822,899 | 13,717,894 | 10.51% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $3,254,296,668 | 13,698,841 | 10.50% | 株式数 |
| STATE STREET CORP | $2,842,909,265 | 11,967,121 | 9.17% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $1,350,305,229 | 5,709,017 | 4.36% | 株式数 |
| WCM INVESTMENT MANAGEMENT, LLC | $971,445,537 | 4,112,461 | 3.13% | 株式数 |
| NORGES BANK | $885,248,810 | 3,726,422 | 2.86% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $499,624,076 | 2,103,149 | 1.61% | 株式数 |
| VICTORY CAPITAL MANAGEMENT INC | $469,793,667 | 1,977,579 | 1.52% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $315,702,986 | 1,328,940 | 1.02% | 株式数 |
| VANGUARD GROUP INC | $277,003,725 | 1,347,950 | 0.89% | 株式数 |
| Robeco Institutional Asset Management B.V. | $258,918,781 | 1,089,909 | 0.84% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $244,584,818 | 1,029,571 | 0.79% | 株式数 |
| ENVESTNET ASSET MANAGEMENT INC | $230,523,823 | 970,390 | 0.74% | 株式数 |
| BlackRock, Inc. | $225,912,433 | 950,970 | 0.73% | 株式数 |
| Man Group plc | $220,862,620 | 929,713 | 0.71% | 株式数 |
| FMR LLC | $211,855,495 | 891,798 | 0.68% | 株式数 |
| GOLDMAN SACHS GROUP INC | $199,229,035 | 838,647 | 0.64% | 株式数 |
| ProShare Advisors LLC | $197,187,154 | 830,052 | 0.64% | 株式数 |
| NORDEA INVESTMENT MANAGEMENT AB | $192,568,890 | 809,283 | 0.62% | 株式数 |
| Legal & General Group Plc | $184,918,605 | 778,408 | 0.60% | 株式数 |
| JANE STREET GROUP, LLC | $169,712,864 | 714,400 | 0.55% | コールオプション |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $160,043,538 | 677,519 | 0.52% | 株式数 |
| Swiss National Bank | $157,644,816 | 663,600 | 0.51% | 株式数 |
| JANE STREET GROUP, LLC | $153,701,320 | 647,000 | 0.50% | プットオプション |
| Mitsubishi UFJ Asset Management Co., Ltd. | $141,722,832 | 596,577 | 0.46% | 株式数 |
| 1832 Asset Management L.P. | $139,039,117 | 585,280 | 0.45% | 株式数 |
| Sumitomo Mitsui Trust Group, Inc. | $132,703,867 | 558,612 | 0.43% | 株式数 |
| RENAISSANCE TECHNOLOGIES LLC | $130,681,756 | 550,100 | 0.42% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $126,454,568 | 532,306 | 0.41% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $123,081,499 | 518,107 | 0.40% | 株式数 |
| Vanguard Global Advisers, LLC | $122,136,010 | 514,127 | 0.39% | 株式数 |
| LPL Financial LLC | $120,559,117 | 507,489 | 0.39% | 株式数 |
| RHUMBLINE ADVISERS | $116,899,342 | 492,084 | 0.38% | 株式数 |
| UBS Group AG | $116,739,360 | 491,410 | 0.38% | 株式数 |
| National Pension Service | $113,432,762 | 477,491 | 0.37% | 株式数 |
| FRED ALGER MANAGEMENT, LLC | $111,665,316 | 470,051 | 0.36% | 株式数 |
| SEI INVESTMENTS CO | $110,593,700 | 465,540 | 0.36% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $109,533,215 | 461,076 | 0.35% | 株式数 |
| BARCLAYS PLC | $108,067,946 | 454,908 | 0.35% | 株式数 |
| LAZARD ASSET MANAGEMENT LLC | $106,528,318 | 448,427 | 0.34% | 株式数 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $104,481,026 | 439,809 | 0.34% | 株式数 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $104,081,450 | 438,127 | 0.34% | 株式数 |
| California Public Employees Retirement System | $103,583,999 | 436,033 | 0.33% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $101,984,508 | 429,300 | 0.33% | コールオプション |
| TWO SIGMA ADVISERS, LP | $96,441,150 | 469,300 | 0.31% | 株式数 |
| JANUS HENDERSON GROUP PLC | $96,030,102 | 454,526 | 0.31% | 株式数 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $95,040,000 | 400,069 | 0.31% | 株式数 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $94,526,074 | 397,904 | 0.30% | 株式数 |
| ING GROEP NV | $90,805,885 | 382,244 | 0.29% | 株式数 |
| Retirement Systems of Alabama | $89,453,931 | 376,553 | 0.29% | 株式数 |
| BANK OF NOVA SCOTIA | $88,870,008 | 374,095 | 0.29% | 株式数 |
| RAYMOND JAMES FINANCIAL INC | $88,654,749 | 373,189 | 0.29% | 株式数 |
| Artemis Investment Management LLP | $87,745,162 | 369,360 | 0.28% | 株式数 |
| TD Asset Management Inc | $85,393,555 | 359,461 | 0.28% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85,236,528 | 358,800 | 0.27% | プットオプション |
| Delta Accumulation, LLC | $81,886,932 | 344,700 | 0.26% | プットオプション |
| STOREBRAND ASSET MANAGEMENT AS | $80,500,769 | 338,865 | 0.26% | 株式数 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $79,269,258 | 333,681 | 0.26% | 株式数 |
| ROYAL BANK OF CANADA | $79,026,000 | 332,656 | 0.25% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $78,334,941 | 370,711 | 0.25% | 株式数 |
| Ensign Peak Advisors, Inc | $78,327,333 | 329,716 | 0.25% | 株式数 |
| GFS Advisors, LLC | $76,777,103 | 55 | 0.25% | 株式数 |
| Integral Health Asset Management, LLC | $71,268,000 | 300,000 | 0.23% | 株式数 |
| Focus Partners Wealth | $69,563,786 | 292,826 | 0.22% | 株式数 |
| ZACKS INVESTMENT MANAGEMENT | $69,526,717 | 292,669 | 0.22% | 株式数 |
| PRUDENTIAL FINANCIAL INC | $69,141,838 | 291,050 | 0.22% | 株式数 |
| FIRST TRUST ADVISORS LP | $63,253,014 | 266,262 | 0.20% | 株式数 |
| Caisse de depot et placement du Quebec | $63,072,655 | 265,502 | 0.20% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $60,514,609 | 254,734 | 0.20% | 株式数 |
| CANADA PENSION PLAN INVESTMENT BOARD | $60,313,158 | 253,886 | 0.19% | 株式数 |
| Gotham Asset Management, LLC | $59,744,915 | 251,494 | 0.19% | 株式数 |
| NATIXIS | $57,996,711 | 244,135 | 0.19% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $57,683,884 | 243,678 | 0.19% | 株式数 |
| AMERIPRISE FINANCIAL INC | $56,823,880 | 239,198 | 0.18% | 株式数 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $56,038,504 | 235,892 | 0.18% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $55,998,840 | 265,008 | 0.18% | 株式数 |
| Vest Financial, LLC | $55,494,016 | 233,600 | 0.18% | 株式数 |
| AVIVA PLC | $54,653,054 | 230,060 | 0.18% | 株式数 |
| COOKSON PEIRCE & CO INC | $54,112,422 | 227,784 | 0.17% | 株式数 |
| APG Asset Management N.V. | $52,132,088 | 250,895 | 0.17% | 株式数 |
| Delta Accumulation, LLC | $50,101,404 | 210,900 | 0.16% | コールオプション |
| Quantinno Capital Management LP | $49,716,731 | 209,280 | 0.16% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $48,954,227 | 206,071 | 0.16% | 株式数 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $48,870,606 | 205,719 | 0.16% | 株式数 |
| Zurich Insurance Group Ltd/FI | $47,315,063 | 199,171 | 0.15% | 株式数 |
| CRAWFORD INVESTMENT COUNSEL INC | $45,812,739 | 192,847 | 0.15% | 株式数 |
| Cetera Investment Advisers | $45,437,576 | 191,268 | 0.15% | 株式数 |
| Empyrean Capital Partners, LP | $43,758,552 | 184,200 | 0.14% | 株式数 |
| Squarepoint Ops LLC | $43,560,427 | 183,366 | 0.14% | 株式数 |
| PFA Pension, Forsikringsaktieselskab | $43,480,161 | 183,028 | 0.14% | 株式数 |
| Davidson Kempner Capital Management LP | $43,260,389 | 182,103 | 0.14% | 株式数 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $42,795,484 | 180,146 | 0.14% | 株式数 |
| Pictet Asset Management Holding SA | $42,685,837 | 179,688 | 0.14% | 株式数 |
| OSAIC HOLDINGS, INC. | $41,443,725 | 174,339 | 0.13% | 株式数 |
| CHURCHILL MANAGEMENT Corp | $40,806,561 | 242,896 | 0.13% | 株式数 |
| JONES FINANCIAL COMPANIES LLLP | $40,701,876 | 171,074 | 0.13% | 株式数 |
| AMF Tjanstepension AB | $40,543,890 | 170,668 | 0.13% | 株式数 |
| Voleon Capital Management LP | $40,128,160 | 168,918 | 0.13% | 株式数 |
| CITADEL ADVISORS LLC | $40,028,860 | 168,500 | 0.13% | コールオプション |
企業インサイダー 85 人のインサイダー · 45人の役員 · 37人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Jason M. Hollar | Chief Executive Officer | 2026年8月19日 S | 190,603 | 0 | 10 | $-29,375,516 |
| Deborah Weitzman | CEO, PSS Segment | 2026年8月18日 S | 77,901 | 0 | 3 | $-1,731,524 |
| Stephen M Mason | CEO, GMPD Segment | 2026年8月18日 S | 18,061 | 0 | 4 | $-8,274,118 |
| Michael C Kaufmann | CEO | 2022年8月15日 M | 601,065 | 0 | 0 | $0 |
| Victor L. Crawford | CEO, Pharmaceutical Segment | 2022年8月15日 F | 105,699 | 0 | 0 | $0 |
| Jon L Giacomin | CEO, Medical Segment | 2019年8月15日 F | 61,387 | 0 | 0 | $0 |
| Donald M Casey Jr. | CEO, Medical Segment | 2017年9月15日 F | 146,503 | 0 | 0 | $0 |
| Michael A Lynch | CEO, Medical Segment | 2012年2月27日 M | 89,204 | 0 | 0 | $0 |
| Kerry R Clark | Former Chairman and CEO | 2009年9月1日 A | 238,635 | 0 | 0 | $0 |
| Mark W Parrish | CEO - HSCS | 2007年9月2日 F | 68,041 | 0 | 0 | $0 |
| Ronald K Labrum | CEO-Supply Chain Svcs. | 2006年5月16日 M | 36,082 | 0 | 0 | $0 |
| Joseph C Papa | Chmn & CEO, Pharm Techn & Svcs | 2004年12月13日 A | 14,400 | 0 | 0 | $0 |
| Aaron E Alt | Chief Financial Officer | 2026年8月18日 S | 20,495 | 0 | 4 | $-9,926,140 |
| Jorge M Gomez | Chief Financial Officer | 2018年11月8日 F | 39,582 | 0 | 0 | $0 |
| Jeffrey William Henderson | Chief Financial Officer | 2014年8月27日 M | 67,190 | 0 | 0 | $0 |
| Richard J Miller | EVP & CFO | 2003年11月17日 A | — | 0 | 0 | $0 |
| George L Fotiades | President & COO | 2003年1月15日 P | 80,278 | 0 | 0 | $0 |
| Mary C. Scherer | Chief Accounting Officer | 2026年8月19日 S | 2,811 | 0 | 2 | $-546,473 |
| Michelle D. Greene | Chief Information Officer | 2026年8月18日 S | 10,330 | 0 | 4 | $-2,746,187 |
| Jessica L Mayer | Chief Legal/Compliance Officer | 2026年8月18日 S | 33,076 | 0 | 4 | $-6,952,485 |
| Valerie Christine Pitteroff | Chief Human Resources Officer | 2026年8月15日 F | 11,757 | 0 | 0 | $0 |
| Ola M Snow | Chief Human Resources Officer | 2025年8月19日 S | 15,431 | 0 | 0 | $0 |
| Patricia M English | Chief Accounting Officer | 2022年8月15日 F | 9,000 | 0 | 0 | $0 |
| Brian S Rice | Chief Information Officer | 2022年8月15日 F | 37,850 | 0 | 0 | $0 |
| Michele Holcomb | EVP - Strategy & Corp. Dev. | 2022年8月15日 F | 44,491 | 0 | 0 | $0 |
| Stuart G Laws | SVP & Chief Accounting Officer | 2020年8月15日 F | 12,289 | 0 | 0 | $0 |
| Craig S Morford | Chief Legal/Compliance Officer | 2018年12月3日 F | 126,301 | 0 | 0 | $0 |
| Patricia Morrison | Chief Information Officer | 2018年8月31日 F | 30,725 | 0 | 0 | $0 |
| Pamela O. Kimmet | Chief Human Resources Officer | 2018年8月15日 F | 22,612 | 0 | 0 | $0 |
| George S Barrett | Executive Chairman | 2018年8月15日 F | 502,630 | 0 | 0 | $0 |
| Carole S Watkins | Chief HR Officer | 2016年5月20日 M | 31,585 | 0 | 0 | $0 |
| Falk T Stephen | EVP, Gen. Counsel & Corp. Sec. | 2015年11月30日 G | 32,455 | 0 | 0 | $0 |
| Meghan Fitzgerald | EVP, Strategy & Health Policy | 2015年11月17日 F | 16,760 | 0 | 0 | $0 |
| Mark R Blake | EVP - Strategy & Corp. Dev. | 2014年11月7日 M | 20,409 | 0 | 0 | $0 |
| Ivan K Fong | CLO & Secretary | 2008年11月1日 F | 50,886 | 0 | 0 | $0 |
| Vivek Jain | EVP - Corp. Dev. & Strategy | 2008年9月26日 A | 39,594 | 0 | 0 | $0 |
| Daniel J Walsh | EVP, Chf Ethcs & Compl Offcr | 2007年11月26日 I | 1,740 | 0 | 0 | $0 |
| Eric Slusser | EVP, CAO & Controller | 2007年6月4日 M | 8,573 | 0 | 0 | $0 |
| Brendan A Ford | EVP-Corporate Development | 2006年9月2日 F | 85,978 | 0 | 0 | $0 |
| RUCCI ANTHONY J | EVP & Chief Admin. Officer | 2005年9月6日 G | 55,382 | 0 | 0 | $0 |
| Gary D Dolch | EVP - Quality & Reg. Affairs | 2005年9月2日 A | 6,137 | 0 | 0 | $0 |
| Jody R Davids | EVP & CIO | 2005年9月2日 A | 4,607 | 0 | 0 | $0 |
| Paul S Williams | EVP, CLO & Secretary | 2005年2月17日 G | 7,000 | 0 | 0 | $0 |
| Gary S Jensen | SVP - Corporate Controller | 2004年8月23日 A | 2,462 | 0 | 0 | $0 |
| Stephen S Thomas | EVP-Group Pres.-AIS | 2004年2月24日 M | 31,039 | 0 | 0 | $0 |
| Hall Patricia Hemingway | 取締役 | 2026年4月15日 A | 28,645 | 0 | 0 | $0 |
| Sheri H. Edison | 取締役 | 2025年11月5日 A | 14,848 | 0 | 0 | $0 |
| Christine Mundkur | 取締役 | 2025年11月5日 A | 7,536 | 0 | 0 | $0 |
| Gregory B Kenny | 取締役 | 2025年11月5日 A | 64,194 | 0 | 0 | $0 |
| Sudhakar Ramakrishna | 取締役 | 2025年3月15日 A | 1,049 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 3保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Cardinal Health, Inc. ×2 提出書類 | 2014年6月5日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2004年7月2日 | — | 初回提出 | — | SEC |
| 未開示の報告者 | 2004年5月28日 | — | 初回提出 | M&A / 売却 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 229のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| EGGS · Tidal Trust III | 4.07% | 11,627 NS | 2026年5月31日 | N-PORT |
| FTXH · First Trust Exchange-Traded Fund VI | 3.53% | 5,386 NS | 2026年6月30日 | N-PORT |
| BCUS · Exchange Listed Funds Trust | 2.96% | 16,250 NS | 2026年5月31日 | N-PORT |
| IYK · iShares Trust | 2.43% | 150,417 SH | 2026年8月21日 | 日次 |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2.18% | 16,977 SH | 2026年8月21日 | 日次 |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.98% | 89,549 NS | 2026年4月30日 | N-PORT |
| NUMV · Nushares ETF Trust | 1.83% | 40,961 NS | 2026年4月30日 | N-PORT |
| DVLU · First Trust Exchange-Traded Fund VI | 1.77% | 3,389 NS | 2026年6月30日 | N-PORT |
| FLOW · Global X Funds | 1.70% | 2,476 NS | 2026年5月31日 | N-PORT |
| ZECP · Zacks Trust | 1.69% | 29,490 NS | 2026年5月31日 | N-PORT |
| COWZ · Pacer Funds Trust | 1.62% | 1,528,597 NS | 2026年4月30日 | N-PORT |
| QQWZ · Pacer Funds Trust | 1.62% | 3,926 NS | 2026年4月30日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.53% | 54,875 SH | 2026年8月21日 | 日次 |
| PWV · Invesco Exchange-Traded Fund Trust | 1.48% | 120,402 SH | 2026年8月21日 | 日次 |
| NOBL · ProShares Trust | 1.41% | 791,661 NS | 2026年5月31日 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1.38% | 796 NS | 2026年4月30日 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1.37% | 239,259 NS | 2026年4月30日 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 1.34% | 23,570 SH | 2026年8月19日 | 日次 |
| RWL · Invesco Exchange-Traded Fund Trust … | 1.31% | 566,085 SH | 2026年8月21日 | 日次 |
| GROZ · Zacks Trust | 1.19% | 5,456 NS | 2026年5月31日 | N-PORT |
| SRHQ · Elevation Series Trust | 1.09% | 10,932 NS | 2026年4月30日 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 1.04% | 6,284 SH | 2026年8月21日 | 日次 |
| RPV · Invesco Exchange-Traded Fund Trust | 1.03% | 77,824 SH | 2026年8月21日 | 日次 |
| NULV · Nushares ETF Trust | 1.03% | 110,401 NS | 2026年4月30日 | N-PORT |
| ESMV · iShares Trust | 1.01% | 350 SH | 2026年8月21日 | 日次 |
| AMOM · Exchange Listed Funds Trust | 1.00% | 1,584 NS | 2026年4月30日 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0.96% | 1,504,470 SH | 2026年8月19日 | 日次 |
| FCFY · First Trust Exchange-Traded Fund | 0.93% | 53 NS | 2026年6月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.82% | 707,389 SH | 2026年8月19日 | 日次 |
| ABFL · Abacus FCF ETF Trust | 0.80% | 20,613 NS | 2026年4月30日 | N-PORT |
| ROE · EA Series Trust | 0.79% | 10,387 NS | 2026年5月29日 | N-PORT |
| VAMO · Cambria ETF Trust | 0.78% | 3,359 NS | 2026年4月30日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.74% | 387 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.74% | 109,528 NS | 2026年4月30日 | N-PORT |
| UPSD · ETF Series Solutions | 0.73% | 3,833 NS | 2026年4月30日 | N-PORT |
| LGDX · Tidal Trust III | 0.69% | 4,947 NS | 2026年4月30日 | N-PORT |
| IWP · iShares Trust | 0.69% | 617,869 SH | 2026年8月21日 | 日次 |
| RXL · ProShares Trust | 0.67% | 2,454 NS | 2026年5月31日 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.66% | 524 NS | 2026年4月30日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.65% | 4,692 NS | 2026年4月30日 | N-PORT |
| IXJ · iShares Trust | 0.65% | 123,272 SH | 2026年8月21日 | 日次 |
| PAPI · Morgan Stanley ETF Trust | 0.59% | 9,872 NS | 2026年6月30日 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.58% | 38,214 NS | 2026年4月30日 | N-PORT |
| QARP · DBX ETF Trust | 0.58% | 2,209 NS | 2026年5月29日 | N-PORT |
| CLSE · Trust for Professional Managers | 0.58% | 18,083 NS | 2026年5月31日 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0.56% | 2,763 NS | 2026年5月31日 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.54% | 5,075,476 SH | 2026年8月19日 | 日次 |
| QUVU · Hartford Funds Exchange-Traded Trust | 0.52% | 4,667 NS | 2026年4月30日 | N-PORT |
| BTAL · AGF Investments Trust | 0.51% | 6,072 NS | 2026年6月30日 | N-PORT |
| ITAN · EA Series Trust | 0.50% | 2,246 NS | 2026年5月29日 | N-PORT |